September Fall Special Edition 2021
The Silicon Review
Company | Management | Description |
Goodwin Biotechnology www.goodwinbio.com |
Karl Pinto CEO |
Goodwin Biotechnology, Inc. (GBI) is a fully integrated, customer-focused cGMP Contract Manufacturing Organization (CMO) of Biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs) and other bioconjugates. |
Lexaria Bioscience www.lexariabioscience.com |
Chris Bunka Chairman of the Board & CEO |
Lexaria Bioscience Corp. has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds. |
Akron Bio www.akronbiotech.com |
Robert “Bob” Wedinger CEO |
Akron is a leading manufacturer of ancillary materials for the cell and gene therapy industry. The company has long understood that the supply of high-quality, well-documented ancillary materials are critical to the scale-up and commercialization of these life-saving therapies. |
Algalif www.algalif.is |
Orri Björnsson CEO |
ALGALIF is a leading supplier of high-grade natural astaxanthin products from Haematococcus pluvialis microalgae, manufactured to rigorous quality and sustainability standards at our cGMP-compliant, indoor facility in Iceland. |
Mammogen Inc www.mammogen.bio |
Elizabeth Cormier-May CEO |
Mammogen is dedicated to meaningfully improving every aspect of women's health. Its flagship genTRU liquid biopsy program is uniquely positioned to address clinically urgent unmet needs across the entire care continuum for breast cancer. From end-to-never-end. |